Seeing the whole picture: How Inizio Ignite helped rebuild prescribing confidence

Authored by: Rebecca Davies, James Linney & Tim Luxford

Better Decisions Come from Different Perspectives

When brand performance starts to decline, it’s natural to question whether the strategy is still right. Markets change, competitors evolve, and external events can quickly alter customer priorities. The challenge is knowing whether the strategy itself needs to change, or whether something else is getting in the way. It is not always possible to answer that question with a single source of evidence.

That is why Inizio Ignite supports clients across the product lifecycle with research and evidence. For this specific case study, Inizio Ignite, Research Partnership provided understanding of how customers think and what shapes their decisions, while Inizio Ignite, STEM examined how commercial strategy is executed in practice by evaluating whether customer conversations align with the intended approach. Together, these complementary capabilities provide insights that inform decision-making at every stage of the product lifecycle.

The following case study shows how that combination of expertise helped a pharmaceutical client identify the real cause of declining performance and respond with confidence.

The Challenge

The Inizio Ignite, Research Partnership team identified an unexpected shift in prescribing trends, signaling that something had changed in the market. Following a recent class-wide regulatory safety update, a previously strong-performing brand began to lose momentum. The initial assumption was that the brand’s strategy had lost relevance, as physicians appeared to be placing greater emphasis on safety considerations in response to the regulatory update.

Inizio Ignite, Research Partnership’s team began by combining custom physician perception tracking with insights from Therapy Watch, Inizio Ignite’s syndicated prescribing data solution. The findings challenged that assumption. Based on this research, physicians continued to prioritize clinical outcomes when making treatment decisions; the brand’s positioning remained aligned with customer needs, and engagement levels were strong. Yet, prescribing share continued to decline, particularly in earlier lines of therapy.

The evidence raised a different question. If physicians still valued the proposition, why wasn’t that being reflected in prescribing behavior?

Connecting the Evidence

Going Beyond the Data

To answer that question, the team turned to field execution. Inizio Ignite, STEM’s evaluation showed that representatives remained knowledgeable, engaged, and committed to supporting customers. However, their conversations had naturally adapted following the class wide safety update. Safety was being addressed earlier and more extensively, and outcome-led messages were often introduced later in the discussion. Opportunities to gain commitment and reinforce the brand’s differentiation were also being missed.

From Insight to Action

Bringing these findings together stress-tested not only the strategy, but the execution. The strategy itself remained relevant, but the way it was being delivered had shifted. Conversations had become weighted towards reassurance, reducing the impact of the outcome-led positioning that had previously differentiated the brand.

That distinction gave the client confidence to act. Rather than redesigning the strategy, the focus shifted to strengthening its execution. Customer conversations were repositioned to lead with outcomes before addressing safety; greater emphasis was placed on patient identification and pre-call planning, and commitment-based selling behaviors were reinforced across the field force.

The Outcome

Over the following months, the decline in share began to stabilize, confidence in the brand improved, and advocacy measures strengthened. Prescribing trends also showed encouraging signs of recovery.

The integrated analysis gave the client confidence in where the challenge lay and where action was needed. Rather than investing time in redesigning a strategy that remained relevant, the client was able to focus on improving how that strategy was delivered in the field. This enabled them to significantly increase revenue year over year while refining their commercialization strategy to capitalize on emerging market opportunities.

Why This Matters

This case study illustrates the value of looking beyond individual data sources. Perception tracking, prescribing trends and field execution each revealed part of the story, but none explained the decline. It was only by bringing those perspectives together that the client was able to distinguish between a strategy that no longer resonated and one that simply wasn’t being delivered as intended.

For commercial leaders, that distinction matters. Changing strategies can be costly and disruptive. Understanding whether the issue lies with the strategy itself or its execution enables organizations to focus effort where it will have the greatest impact.

The ability to connect research, data, and field insight across the product lifecycle gives teams a clearer understanding of where performance is being impacted. Rather than relying on isolated data points, organizations can make more confident decisions about whether to refine their strategy or strengthen its execution. Working with a single partner that brings these complementary capabilities together also enables a more connected, collaborative approach to commercial decision-making. To learn more about how Inizio Ignite helps organizations turn integrated evidence into confident action, visit our website.